Boosting with AstraZeneca’s vaccine provides high protection against Omicron, equivalent to mRNA COVID-19 vaccines

Boosting with AstraZeneca’s vaccine and mRNA COVID-19 vaccines provide equally high protection against Omicron-related severe outcomes, including hospitalisation and death, even as new subvariants of the virus emerge, according to an expert review of more than 50 real-world studies. The Read More …

AstraZeneca’s COVID-19 vaccine estimated to have prevented 232,766 deaths in Vietnam

With more than 72 million doses delivered to Vietnam, AstraZeneca’s COVID-19 vaccine is one of the most used in the country and is estimated to have prevented 232,766 deaths locally, an independent assessment of vaccine effectiveness shows.1,2 AstraZeneca’s vaccine was Read More …

AstraZeneca to supply the US government with an additional one million doses of Evusheld long-acting antibody combination for the prevention of COVID-19

Builds on initial US government agreement, now totalling 1.7 million doses  Only antibody therapy authorized in the US for pre-exposure prophylaxis of COVID-19 in people who are immunocompromised AstraZeneca today announced the US Department of Health and Human Services has Read More …

Vaxzevria significantly boosted antibody levels against Omicron

University of Oxford study supports use of Vaxzevria as third dose booster against Omicron Neutralising antibody levels against Omicron following a third dose boost of Vaxzevria were broadly similar to levels achieved after two doses against the Delta variant AstraZeneca’s Read More …

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study

Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19 In this pre-clinical study, Evusheld’s Inhibitory Concentration 50 (IC50), a measure of neutralising potency of an antibody, was 171 ng/ml and 277 ng/ml in two confirmatory tests, which is within the Read More …

30 million vaccine doses delivered to Vietnam via AstraZeneca-VNVC partnership

AstraZeneca and Vietnam Vaccine JSC (VNVC) have delivered an additional 1,547,100 doses of COVID-19 Vaccine AstraZeneca (also known as Vaxzevria) to Vietnam, reaching the milestone of 30 million doses and completing the first phase of the companies’ vaccine supply partnership, Read More …

Evusheld (formerly AZD7442) long-acting antibody combination authorised for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19

Only antibody therapy authorised in US for pre-exposure prophylaxis   Pivotal phase III data showed robust efficacy and long-term protection with one dose in high-risk population  AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody (LAAB) combination, has received emergency Read More …

More than 1.2 million doses of AstraZeneca’s COVID-19 vaccine arrive in Vietnam

Vietnam Prime Minister and AstraZeneca CEO had bilateral telephone conversation today AstraZeneca delivered another 1,209,400 doses of its COVID-19 vaccine to Vietnam. The delivery is the ninth to Vietnam in total as part of the advance purchase agreement (APA) between Read More …

Almost 600,000 additional doses of AstraZeneca’s COVID-19 vaccine arrive in Vietnam

AstraZeneca delivered 592,100 additional doses of its COVID-19 vaccine for use in Vietnam on August 6th, 2021. The delivery is the seventh to Vietnam in total as part of the advance purchase agreement between AstraZeneca and Vietnam Vaccine JSC (VNVC), Read More …